3LAZ

GraniteShares 3x Long AstraZeneca Daily ETP

Product Description

GraniteShares 3x Long AstraZeneca Daily ETP is a collateralised, Exchange-Traded Product (ETP). The ETP tracks, excluding fees and other adjustments, the performance of the - that seeks to provide 3 times the daily performance of AstraZeneca PLC, (AZN).

For example, if AstraZeneca PLC rises by 1% over a day, then the ETP will rise by 3%, excluding fees and other adjustments. However, if AstraZeneca PLC falls by 1% over a day, then the ETP will fall by 3%, excluding fees and other adjustments.

Underlying Stock: AstraZeneca PLC.

AstraZeneca PLC is a biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. Its key areas include oncology, rare diseases, cardiovascular, renal and metabolic conditions, respiratory and immunology, and vaccines and immune therapies. The company develops and markets a range of treatments, including Tagrisso, Imfinzi, Lynparza, Calquence, Farxiga, Ultomiris, Soliris, Breztri, and others. AstraZeneca also engages in vaccine development and T-cell receptor therapies. It operates globally, serving healthcare providers and patients across the United Kingdom, the United States, Europe, and Asia. Founded in 1992 and headquartered in Cambridge, UK, AstraZeneca was formerly known as Zeneca Group PLC before adopting its current name in 1999.

3LAZ Fact Summary

Tickers (Trading Currency) 3LAZ
ISIN
Underlying Stock AstraZeneca PLC
Leveraged Factor3x
Base Currency GBP
Value per ETP Security as of --
Total Daily Ongoing Cost-
DividendReinvested
Best ETP Provider

ETP SECURITY OVERVIEW

Base Currency GBP
Listing Date -
Dividend Treatment Reinvested
Exchange Ticker 3LAZ
Index Name -

DAILY PERFOMANCE (AS OF -

Value Per ETP Security -
Daily Change -
Daily Return -
AUM -

STRUCTURE

Structure ETP
Replication Method Synthetic
Domicile Ireland

ACCOUNT ELEGIBILITY AND TAX STATUS

ISA Eligible
SIPP Eligible
UK Reporting Status Yes

KEY SERVICE PROVIDERS

Issuer GraniteShares Financial Plc
Issuing and Paying Agent The Bank of New York Mellon, London Branch
Trustee BNY Mellon Corporate Trustee Services Ltd
Swap Provider Natixis
Swap Collateral Custodian The Bank of New York Mellon SA/NV
Auditor Grant Thornton

INDEX DETAILS

Index Name -
Base Trading Currency GBP
Index Provider Solactive
Index Ticker -
Leverage Factor 3x

REGISTERED COUNTRIES

UK
Ireland

PASSPORTED COUNTRIES

Austria
Belgium
Denmark
Finland
France
Germany
Italy
Netherlands
Luxembourg
Norway
Portugal
Spain
Sweden

3LAZ Details

Listing & Codes

View Listing
Exchange Trading Currency Ticker ISIN SEDOL WKN
Performance Details View Performance
Data as of Download performance history Download performance history
All Data on Total Return Basis 1 Month 3 Months YTD 1 Year 3 Years Since Inception

Portfolio

View Portfolio
Fund Sector Breakdown
as of -
Sector Allocation Healthcare 100.00%
Fund Sector Breakdown are subject to change
Top 10 Fund Exposures
as of -
Underlying Allocation AstraZeneca PLC 100.00%
Top 10 Fund Exposures are subject to change

Distribution

Distribution
Fund Yield as of
30-Day SEC Yield N/A Distribution Rate N/A 12 Month Distribution N/A
Distribution Calendar as of
Ex Date Record Date Pay Date $/Share Ordinary Income Short Term Gains Long Term Gains
Distributions are not guaranteed
Collateral Details Collateral
Collateral Coverage Ratio 100%
Collateralised Yes
Collateral Custodian The Bank of New York Mellon SA/NV

Collateral Documents

Collateral Factsheet Download
Collateral Holdings Download Collateral Holdings

Understanding Collateral

Collateralised ETP Securities are backed with collateral, subject to eligibility criteria, to protect investors in event of default. The amount of collateral posted by the Swap Counterparty is held and valued by an independent custodian in a segregated account and is adjusted daily and reflects the collateralised ETPs' change in value and in the outstanding number of securities. The Bank of New York Mellon SA/NV serves as the Swap Collateral Custodian.

Investor Documents

View Documents
Ex Data Document Type 3LAZ- KID EN - EU Regulatory Download 3LAZ- KID EN - EU 3LAZ - KID EN - UK Regulatory Download 3LAZ - KID EN - UK KID Graniteshares 3X Long Astrazeneca Daily ETP Fr Regulatory Download KID Graniteshares 3X Long Astrazeneca Daily ETP Fr 3LAZ - KID IT Regulatory Download 3LAZ - KID IT 3LAZ - KID FI Regulatory Download 3LAZ - KID FI 3LAZ - KID NL Regulatory Download 3LAZ - KID NL 3LAZ - KID ES Regulatory Download 3LAZ - KID ES 3LAZ - KID DE Regulatory Download 3LAZ - KID DE 3LAZ - KID DA Regulatory Download 3LAZ - KID DA 3LAZ - KID PT Regulatory Download 3LAZ - KID PT 3LAZ - KID PL Regulatory Download 3LAZ - KID PL Final Terms(EU) Regulatory Download Final Terms(EU) Base Prospectus (UK) Regulatory Download Base Prospectus (UK) Base Prospectus (EU) Regulatory Download Base Prospectus (EU) Index Methodology Regulatory Download Index Methodology GraniteShares Financial Plc – Annual Accounts June 2025 (pdf) Regulatory Download GraniteShares Financial Plc – Annual Accounts June 2025 (pdf) GraniteShares Financial Plc – Annual Accounts June 2025 (xhtml) Regulatory Download GraniteShares Financial Plc – Annual Accounts June 2025 (xhtml) GraniteShares Financial Plc – Annual Interim Dec 2024 (pdf) Regulatory Download GraniteShares Financial Plc – Annual Interim Dec 2024 (pdf) GraniteShares Financial Plc – Annual Accounts June 2024 (pdf) Regulatory Download GraniteShares Financial Plc – Annual Accounts June 2024 (pdf) GraniteShares Financial Plc – Annual Accounts December 2025 (pdf) Regulatory Download GraniteShares Financial Plc – Annual Accounts December 2025 (pdf) GraniteShares Financial Plc – Annual Accounts December 2025 (xhtml) Regulatory Download GraniteShares Financial Plc – Annual Accounts December 2025  (xhtml) Product List Marketing Download Product List Factsheet Graniteshares 3X Long Astrazeneca Daily ETP It Marketing Download Factsheet Graniteshares 3X Long Astrazeneca Daily ETP It Factsheet Graniteshares 3X Long Astrazeneca Daily ETP En Marketing Download Factsheet Graniteshares 3X Long Astrazeneca Daily ETP En Factsheet Graniteshares 3X Long Astrazeneca Daily ETP Fr Marketing Download Factsheet Graniteshares 3X Long Astrazeneca Daily ETP Fr GraniteShares Financial Plc – 2025 UK Reporting Status UK Reporting Fund Status Download GraniteShares Financial Plc – 2025 UK Reporting Status GraniteShares Financial Plc – 2024 UK Reporting Status UK Reporting Fund Status Download GraniteShares Financial Plc – 2024 UK Reporting Status GraniteShares Financial Plc – 2023 UK Reporting Status Archieved Download GraniteShares Financial Plc – 2023 UK Reporting Status GraniteShares Financial Plc – 2022 UK Reporting Status Archieved Download GraniteShares Financial Plc – 2022 UK Reporting Status GraniteShares Financial Plc – 2021 UK Reporting Status Archieved Download GraniteShares Financial Plc – 2021 UK Reporting Status GraniteShares Financial Plc – 2020 UK Reporting Status Archieved Download GraniteShares Financial Plc – 2020 UK Reporting Status GraniteShares Financial Plc – Annual Accounts June 2023 (pdf) Archieved Download GraniteShares Financial Plc – Annual Accounts June 2023 (pdf) GraniteShares Financial Plc – Annual Accounts June 2023 (xHTML) Archieved Download GraniteShares Financial Plc – Annual Accounts June 2023 (xHTML) GraniteShares Financial plc – Interim Accounts December 2023 (pdf) Archieved Download GraniteShares Financial plc – Interim Accounts December 2023 (pdf) GraniteShares Financial plc – Interim Accounts December 2023 (xHTML) Archieved Download GraniteShares Financial plc – Interim Accounts December 2023 (xHTML) GraniteShares Financial plc - Interim Accounts December 2022 Archieved Download GraniteShares Financial plc - Interim Accounts December 2022 GraniteShares Financial Plc – Annual Accounts June 2022 (pdf) Archieved Download GraniteShares Financial Plc – Annual Accounts June 2022 (pdf) GraniteShares Financial Plc – Annual Accounts June 2022 (xHTML) Archieved Download GraniteShares Financial Plc – Annual Accounts June 2022 (xHTML) GraniteShares Financial Plc – Interim Account December 2021 Archieved Download GraniteShares Financial Plc – Interim Account December 2021 GraniteShares Financial Plc -Annual Accounts June 2021 Archieved Download GraniteShares Financial Plc -Annual Accounts June 2021 GraniteShares Financial Plc Interim Accounts December 2020 Archieved Download GraniteShares Financial Plc Interim Accounts December 2020 GraniteShares Financial Plc Annual Accounts June 2020 Archieved Download GraniteShares Financial Plc Annual Accounts June 2020 GraniteShares Financial Plc Interim Accounts December 2019 Archieved Download GraniteShares Financial Plc Interim Accounts December 2019
Premium/Discount Data & Charts
Latest Premium Discount Premium Discount Details
Latest Premium Discount
as of June 13, 2025
NAVCONI PriceCONI Premium / (Discount)CONI
Data for the current quarter
as of June 13, 2025
Days at PremiumCONI Days at NAVCONI Days at DiscountCONI
-Year 2024 Days at PremiumCONICONI Days at NAVCONICONI Days at DiscountCONICONI
as of March 31, 2025 Greatest PremiumCONI Greatest DiscountCONI Days Between -0.5% to 0.0%CONI Days Between 0.0% to 0.5%CONI
Historical Premium/Discount Chart Historical Premium Discount Details
as of March 31, 2025

Chart Description

The amount the Fund is trading above or below the reported NAV expressed as a percentage of the NAV. When the fund's market price is greater than the fund's NAV, it is said to be trading at a "Premium" and the percentage is expressed as a positive number. When the fund's market price is less than the fund's NAV, it is said to be trading at a "Discount" and the percentage is expressed as a negative number.


Premium/Discount Frequency

as of March 31, 2025

Chart Description

The above chart presents information about the difference between the daily market price for shares of the Fund and the Fund’s net asset value (or NAV). The market price is the last price as published by the exchange on which the Fund is listed. It is generally the average of the bid-ask prices at 4:00 PM ET. The NAV is calculated by reference to the closing price of the positions held by the Fund. The vertical axis of the chart shows the premium or discount of the market price as percentage of the NAV. The horizontal axis shows the number of trading days in the period covered by the chart. Each bar in the chart shows the number of trading days in which the Fund traded within the premium/discount range indicated.

Possible Time Discrepancies

The primary explanation is that timing discrepancies can arise between the NAV and the closing price of the Fund. Since shares of the Fund trade on the open market, prices are affected by the constant flow of information received by investors, corporations and financial institutions. Depending on how this changing information affects investor sentiment, shares of the Fund may deviate slightly from the value of the Fund's underlying assets. As a result, shareholders may pay more than NAV when they buy Fund shares and receive less than NAV when they sell those shares, because shares are purchased and sold at current market prices. However, due to the creation and redemption process that is unique to ETFs, market makers are able to minimize these deviations from NAV by taking advantage of arbitrage opportunities.

Search

Popular Topics Popular

Terms